ArticleRheumatology international2026
Late onset axial spondyloarthritis presenting with fever of unknown origin. A case-based review.
Article in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Lower HLA-B27 positivity and heterogeneous late-onset case proportions across axial spondyloarthritis cohorts: a systematic review and meta-analysis.Rheumatology international · 2026Pooled it
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spondyloarthritis (SpA) is a chronic inflammatory disease involving axial (ax-SpA), and peripheral joints (p-SpA). It mainly affects young individuals and symptoms begin before the age of 45 years. Late onset (LO) ax-SpA, presenting after the age of 50, is rare. It is usually underdiagnosed in favor of other disorders, which are very common in this population. A 70-year-old woman presented with fever of unknown origin (FUO), back pain, malaise, weakness and high acute phase reactants, without any other clinical or laboratory findings. After an intensive and extensive investigation, to exclude several diseases and disorders, our patient, despite being old and almost asymptomatic for SpA features was diagnosed as having LO-axSpA. The patient was treated successfully with adalimumab. We discuss the differential diagnosis of FUO in an elderly woman with constitutional symptoms and elevated inflammatory markers. This is the first case of LO-axSpA presenting with FUO, therefore, physicians must be aware of rare manifestations of ax-SpA in the elderly population. Rigorous and extensive investigation is required to reach the correct diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.